2. Academic Validation
  3. Discovery of antibacterial and synergistic acylhydrazone functionalized α-mangostin derivatives against drug-resistant pathogens

Discovery of antibacterial and synergistic acylhydrazone functionalized α-mangostin derivatives against drug-resistant pathogens

  • Bioorg Chem. 2025 Nov:166:109108. doi: 10.1016/j.bioorg.2025.109108.
Qun Tang 1,  Haiyang Zhang 2,  Zirui Jiao 1,  Han Bai 3,  Xiangan Han 1,  Xiaoyang Wang 1,  Keyu Zhang 1,  Chunmei Wang 4,  Wen Zhou 5
Affiliations

Affiliations

  • 1 Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 200241, Shanghai, China; Key laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China.
  • 2 Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 200241, Shanghai, China.
  • 3 Department of Clinical Pharmacy, College of Pharmacy, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, 541199, PR China.
  • 4 Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 200241, Shanghai, China; Key laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China. Electronic address: wangchunmei@shvri.ac.cn.
  • 5 Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 200241, Shanghai, China; Key laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs, Shanghai Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China. Electronic address: zhouwen60@126.com.
PMID: 41109067 DOI: 10.1016/j.bioorg.2025.109108
Abstract

By strategically combining the acylhydrazone scaffold with α-mangostin (α-MG)'s membrane-targeting properties, we designed 48 novel conjugates to enhance Antibacterial potential and biofilm penetration while reducing toxicity. The candidate compound 7-8 demonstrated exceptional anti-Methicillin-Resistant Staphylococcus aureus (MRSA) activity (MIC = 1 μg/mL) with in vivo efficacy (5 mg/kg, s.c.) comparable to vancomycin. 7-8 exhibited superior safety profiles versus α-MG, including minimal cytotoxicity (IC50 > 100 μg/mL in A549/LO-2 cells), negligible hemolysis (HC50 > 400 μg/mL), excellent in vivo tolerance, and no genotoxicity. Mechanistic studies revealed a dual Antibacterial action: i) membrane disruption causing cellular content leakage, and ii) ROS-mediated oxidative stress. 7-8 also showed remarkable biofilm inhibition/eradication capacity through downregulation of key biofilm genes (ica, agr). Pharmacokinetic evaluation revealed favorable metabolic stability, moderate plasma protein binding, and optimal lipophilicity. These results established 7-8 as a promising multi-target therapeutic candidate against drug-resistant infections, combining enhanced biofilm penetration with improved safety.

Keywords

MRSA; acylhydrazone; antibacterial; synergistic effect; α-Mangostin.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z